Gil Atzmon
Gil Atzmon is Professor of Human Biology at Haifa University in Israel, where he runs the Laboratory of Genetics and Epigenetics of Aging and Longevity, and at Albert Einstein College of Medicine in New York. The foremost focus of Prof. Gil Atzmon’s entire research career has been the understanding of the association of the whole genome to disease, performance, health and longevity. Since 2001, he has focused on human genome and its impact on aging and longevity.
He has international collaborations with scientists and researchers across the world and has more than 120 scientific publications in leading scientific journals. He has been invited to present his work in numerous international scientific conferences and meetings, and has been an expert reviewer for many leading scientific journals on genetics and genomics. He also serves on the editorial board of several journals. He has remarkable experience utilizing the most advanced genomic tools and has specific expertise in molecular genetics of longevity. He possesses the ability to combine basic genetics, genomics and bioinformatics tools to perform novel and state-of-the-art analyses that enhance our understanding of the role of genetics and age-related diseases. In more recent years his focus has shifted to a new and challenging field involving the role of epigenetics in aging and longevity.
He has international collaborations with scientists and researchers across the world and has more than 120 scientific publications in leading scientific journals. He has been invited to present his work in numerous international scientific conferences and meetings, and has been an expert reviewer for many leading scientific journals on genetics and genomics. He also serves on the editorial board of several journals. He has remarkable experience utilizing the most advanced genomic tools and has specific expertise in molecular genetics of longevity. He possesses the ability to combine basic genetics, genomics and bioinformatics tools to perform novel and state-of-the-art analyses that enhance our understanding of the role of genetics and age-related diseases. In more recent years his focus has shifted to a new and challenging field involving the role of epigenetics in aging and longevity.